GlassScriptPhysician profile
Sima Cahsai
NPI 1356059216
$2,345.78
in general payments reported to CMS, 2019-2025
22 companies · $888 in 2025
The $888 reported for 2025 was more than what 86% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $562 · 2024: $896 · 2025: $888.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,346.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,345.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $452.71 | 2023-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $340.28 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $257.23 | 2023-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $166.99 | 2025 | |
| Impulse Dynamics (USA) INC. | $166.97 | 2023 | Optimizer |
| Amgen INC. | $130.10 | 2024-2025 | Repatha |
| Alnylam Pharmaceuticals INC. | $116.02 | 2023-2024 | Amvuttra |
| Kiniksa Pharmaceuticals International, Plc | $108.92 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $96.33 | 2023-2025 | Farxiga, Wainua |
| Inspire Medical Systems, INC. | $82.54 | 2025 | Inspire |
| Boston Scientific Corporation | $77.01 | 2023-2025 | Watchman Flx, Wavewriter Alpha Prime 16 |
| Merck Sharp & Dohme LLC | $72.72 | 2023-2025 | Verquvo, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $48.60 | 2023-2024 | Camzyos |
| Lantheus Medical Imaging, INC. | $37.79 | 2025 | |
| Irhythm Technologies, INC. | $36.06 | 2024 | Zio Monitor, Zio Xt Patch |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $28.07 | 2025 | |
| Janssen Pharmaceuticals, INC | $25.55 | 2024 | Xarelto |
| Kiniksa Pharmaceuticals, LTD. | $25.08 | 2023 | Arcalyst |
| Abiomed | $22.62 | 2024 | Impella |
| Recor Medical INC | $22.12 | 2025 | Paradise Ultrasound Renal Denervation System |
| Altathera Pharmaceuticals LLC | $17.73 | 2025 | Sotalol Hydrochloride |
| Kestra Medical Technology Services, INC. | $14.34 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sima Cahsai listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.